189,675 Shares in Heartflow, Inc. $HTFL Acquired by Lisanti Capital Growth LLC

Lisanti Capital Growth LLC bought a new stake in Heartflow, Inc. (NASDAQ:HTFL) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 189,675 shares of the company’s stock, valued at approximately $5,565,000.

Other hedge funds also recently bought and sold shares of the company. Sei Investments Co. lifted its position in shares of Heartflow by 342.5% in the first quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock valued at $1,631,000 after acquiring an additional 51,895 shares in the last quarter. Quantinno Capital Management LP purchased a new stake in Heartflow during the 1st quarter worth about $1,734,000. Walleye Capital LLC purchased a new stake in Heartflow during the 2nd quarter worth about $8,760,000. Royal Bank of Canada raised its stake in Heartflow by 24.4% in the 1st quarter. Royal Bank of Canada now owns 137,421 shares of the company’s stock valued at $3,343,000 after purchasing an additional 26,912 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its holdings in Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after purchasing an additional 1,315,416 shares in the last quarter.

Heartflow Price Performance

HTFL opened at $45.53 on Thursday. The stock has a market capitalization of $3.96 billion and a price-to-earnings ratio of -24.88. The business has a 50-day moving average of $30.00 and a two-hundred day moving average of $28.05. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $47.23.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million for the quarter. The company’s quarterly revenue was up 47.7% on a year-over-year basis. Equities research analysts anticipate that Heartflow, Inc. will post -0.82 earnings per share for the current year.

Insider Buying and Selling

In other Heartflow news, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction on Monday, August 17th. The shares were sold at an average price of $41.23, for a total value of $380,099.37. Following the transaction, the insider owned 86,459 shares in the company, valued at $3,564,704.57. This trade represents a 9.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 38,900 shares of the business’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00. Following the sale, the chief executive officer directly owned 457,935 shares of the company’s stock, valued at $16,027,725. This represents a 7.83% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 131,365 shares of company stock worth $4,257,216. 7.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on HTFL. JPMorgan Chase & Co. raised their price target on shares of Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Wells Fargo & Company upped their price objective on shares of Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. William Blair began coverage on shares of Heartflow in a research report on Monday, May 4th. They set an “outperform” rating on the stock. Stifel Nicolaus lifted their target price on shares of Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. Finally, Benchmark reiterated a “buy” rating on shares of Heartflow in a report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Heartflow currently has an average rating of “Moderate Buy” and a consensus target price of $43.43.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.